The NIHR Diagnostic Evidence Co-operative Leeds is keen to develop Horizon 20:20 applications with UK and European small to medium sized enterprises (SMEs) with biomarker/diagnostic tests of potential benefit to patients and the NHS.

 For more information please contact us or refer to the following sites: